• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者无复流的机器学习预测

Machine learning prediction of no reflow in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

作者信息

Wang Lin, Bao Pei, Wang Xiaochen, Xu Banglong, Liu Zeyan, Hu Guangquan

机构信息

Department of Cardiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.

Department of Emergency Internal Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.

出版信息

Cardiovasc Diagn Ther. 2024 Aug 31;14(4):547-562. doi: 10.21037/cdt-24-83. Epub 2024 Aug 8.

DOI:10.21037/cdt-24-83
PMID:39263488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11384450/
Abstract

BACKGROUND

No-reflow (NRF) phenomenon is a significant challenge in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI). Accurate prediction of NRF may help improve clinical outcomes of patients. This retrospective study aimed at creating an optimal model based on machine learning (ML) to predict NRF in these patients, with the additional objective of guiding pre- and intra-operative decision-making to reduce NRF incidence.

METHODS

Data were collected from 321 STEMI patients undergoing pPCI between January 2022 and May 2023, with the dataset being randomly divided into training and internal validation sets in a 7:3 ratio. Selected features included pre- and intra-operative demographic data, laboratory parameters, electrocardiogram, comorbidities, patients' clinical status, coronary angiographic data, and intraoperative interventions. Post comprehensive feature cleaning and engineering, three logistic regression (LR) models [LR-classic, LR-random forest (LR-RF), and LR-eXtreme Gradient Boosting (LR-XGB)], a RF model and an eXtreme Gradient Boosting (XGBoost) model were developed within the training set, followed by performance evaluation on the internal validation sets.

RESULTS

Among the 261 patients who met the inclusion criteria, 212 were allocated to the normal flow group and 49 to the NRF group. The training group consisted of 183 patients, while the internal validation group included 78 patients. The LR-XGB model, with an area under the curve (AUC) of 0.829 [95% confidence interval (CI): 0.779-0.880], was selected as the representative model for logistic regression analyses. The LR model had an AUC slightly lower than XGBoost model (AUC 0.835, 95% CI: 0.781-0.889) but significantly higher than RF model (AUC 0.731, 95% CI: 0.660-0.802). Internal validation underscored the unique advantages of each model, with the LR model demonstrating the highest clinical net benefit at relevant thresholds, as determined by decision curve analysis. The LR model encompassed seven meaningful features, and notably, thrombolysis in myocardial infarction flow after initial balloon dilation (TFAID) was the most impactful predictor in all models. A web-based application based on the LR model, hosting these predictive models, is available at https://l7173o-wang-lyn.shinyapps.io/shiny-1/.

CONCLUSIONS

A LR model was successfully developed through ML to forecast NRF phenomena in STEMI patients undergoing pPCI. A web-based application derived from the LR model facilitates clinical implementation.

摘要

背景

无复流(NRF)现象是接受直接经皮冠状动脉介入治疗(pPCI)的ST段抬高型心肌梗死(STEMI)患者面临的一项重大挑战。准确预测NRF可能有助于改善患者的临床结局。这项回顾性研究旨在创建一个基于机器学习(ML)的优化模型,以预测这些患者的NRF,另外一个目标是指导术前和术中决策,以降低NRF发生率。

方法

收集了2022年1月至2023年5月期间接受pPCI的321例STEMI患者的数据,数据集以7:3的比例随机分为训练集和内部验证集。选择的特征包括术前和术中的人口统计学数据、实验室参数、心电图、合并症、患者临床状况、冠状动脉造影数据和术中干预措施。经过全面的特征清理和工程处理后,在训练集中开发了三个逻辑回归(LR)模型[LR-经典模型、LR-随机森林(LR-RF)和LR-极限梯度提升(LR-XGB)]、一个随机森林(RF)模型和一个极限梯度提升(XGBoost)模型,随后在内部验证集上进行性能评估。

结果

在符合纳入标准的261例患者中,212例被分配到正常血流组,49例被分配到NRF组。训练组由183例患者组成,而内部验证组包括78例患者。LR-XGB模型的曲线下面积(AUC)为0.829[95%置信区间(CI):0.779-0.880],被选为逻辑回归分析的代表性模型。LR模型的AUC略低于XGBoost模型(AUC 0.835,95%CI:0.781-0.889),但显著高于RF模型(AUC 0.731,95%CI:0.660-0.802)。内部验证突出了每个模型的独特优势,决策曲线分析确定,LR模型在相关阈值下显示出最高的临床净效益。LR模型包含七个有意义的特征,值得注意的是,初始球囊扩张后的心肌梗死溶栓血流(TFAID)是所有模型中最具影响力的预测因素。基于LR模型的网络应用程序托管这些预测模型,可在https://l7173o-wang-lyn.shinyapps.io/shiny-1/上获取。

结论

通过机器学习成功开发了一个LR模型,用于预测接受pPCI的STEMI患者的NRF现象。基于LR模型的网络应用程序便于临床实施。

相似文献

1
Machine learning prediction of no reflow in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者无复流的机器学习预测
Cardiovasc Diagn Ther. 2024 Aug 31;14(4):547-562. doi: 10.21037/cdt-24-83. Epub 2024 Aug 8.
2
Development and validation of a prognostic model for predicting post-discharge mortality risk in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).ST 段抬高型心肌梗死(STEMI)患者行直接经皮冠状动脉介入治疗(PPCI)后出院后死亡风险预测的预后模型的建立与验证。
J Cardiothorac Surg. 2024 Mar 30;19(1):163. doi: 10.1186/s13019-024-02665-3.
3
Predicting no-reflow phenomenon prior to primary percutaneous coronary intervention using a novel probability risk score derived from clinical and angiographic parameters.应用一种基于临床和造影参数的新型概率风险评分模型预测直接经皮冠状动脉介入治疗前无复流现象。
Eur Rev Med Pharmacol Sci. 2022 Feb;26(3):759-770. doi: 10.26355/eurrev_202202_27984.
4
Machine learning to predict no reflow and in-hospital mortality in patients with ST-segment elevation myocardial infarction that underwent primary percutaneous coronary intervention.机器学习预测行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者无复流和住院死亡率。
BMC Med Inform Decis Mak. 2022 Apr 24;22(1):109. doi: 10.1186/s12911-022-01853-2.
5
Effect of preoperative loading dose ticagrelor and clopidogrel on no-reflow phenomenon during intervention in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis.术前负荷剂量替格瑞洛和氯吡格雷对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者介入过程中无复流现象的影响:一项系统评价和荟萃分析。
Drug Des Devel Ther. 2018 Jul 4;12:2039-2049. doi: 10.2147/DDDT.S165431. eCollection 2018.
6
Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.ST段抬高型心肌梗死患者入院时单核细胞计数与直接经皮冠状动脉介入治疗后血管造影无复流的相关性。
Kardiol Pol. 2016;74(10):1160-1166. doi: 10.5603/KP.a2016.0065. Epub 2016 May 10.
7
[The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].[ST段抬高型心肌梗死患者经皮冠状动脉介入治疗前冠状动脉内注射尼可地尔对心肌灌注及临床结局的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jan 25;45(1):26-33. doi: 10.3760/cma.j.issn.0253-3758.2017.01.006.
8
Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.纤维蛋白原与白蛋白比值对预测接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者无复流及短期预后的价值
Heart Vessels. 2019 Oct;34(10):1600-1607. doi: 10.1007/s00380-019-01399-w. Epub 2019 Apr 16.
9
Development of a machine learning model to predict the risk of late cardiogenic shock in patients with ST-segment elevation myocardial infarction.开发一种机器学习模型以预测ST段抬高型心肌梗死患者发生晚期心源性休克的风险。
Ann Transl Med. 2021 Jul;9(14):1162. doi: 10.21037/atm-21-2905.
10
Platelet/lymphocyte ratio for prediction of no-reflow phenomenon in ST-elevation myocardial infarction managed with primary percutaneous coronary intervention.血小板/淋巴细胞比值预测直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者无复流现象
J Clin Transl Res. 2020 Jul 8;6(1):20-26. doi: 10.18053/jctres.06.202001.004. eCollection 2020 Jul 16.

本文引用的文献

1
Coronary No-Reflow after Primary Percutaneous Coronary Intervention-Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy.直接经皮冠状动脉介入治疗后的冠状动脉无复流——关于病理生理学、诊断、临床影响及治疗的当前认知
J Clin Med. 2023 Aug 27;12(17):5592. doi: 10.3390/jcm12175592.
2
2023 ESC Guidelines for the management of acute coronary syndromes.2023年欧洲心脏病学会急性冠状动脉综合征管理指南。
Eur Heart J. 2023 Oct 12;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191.
3
No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL Trial.
ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后无复流:TOTAL 试验的血管造影核心实验室分析。
EuroIntervention. 2023 Aug 7;19(5):e394-e401. doi: 10.4244/EIJ-D-23-00112.
4
Establishment and evaluation of a novel practical tool for the diagnosis of pre-sarcopenia in young people with diabetes mellitus.建立并评估一种用于诊断年轻糖尿病患者肌少症前期的新型实用工具。
J Transl Med. 2023 Jun 17;21(1):393. doi: 10.1186/s12967-023-04261-w.
5
Machine learning-enabled risk prediction of chronic obstructive pulmonary disease with unbalanced data.基于机器学习的慢性阻塞性肺疾病不平衡数据风险预测
Comput Methods Programs Biomed. 2023 Mar;230:107340. doi: 10.1016/j.cmpb.2023.107340. Epub 2023 Jan 6.
6
Influence of Stent Length on Periprocedural Outcomes After Primary Percutaneous Coronary Intervention in Patients with ST Segment Elevation Myocardial Infarction.支架长度对 ST 段抬高型心肌梗死患者直接经皮冠状动脉介入治疗围术期结局的影响。
Clin Interv Aging. 2022 Nov 28;17:1687-1695. doi: 10.2147/CIA.S389302. eCollection 2022.
7
A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis.基于ST段抬高型心肌梗死患者快速获取的患者数据的直接经皮冠状动脉介入术后无复流的列线图风险预测模型及其与预后的关系。
Front Cardiovasc Med. 2022 Aug 8;9:966299. doi: 10.3389/fcvm.2022.966299. eCollection 2022.
8
Assessment of the Efficacy and Safety of Early Intracoronary Nicorandil Administration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.早期冠状动脉内给予尼可地尔对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者疗效和安全性的评估
Cureus. 2022 May 26;14(5):e25349. doi: 10.7759/cureus.25349. eCollection 2022 May.
9
Machine learning to predict no reflow and in-hospital mortality in patients with ST-segment elevation myocardial infarction that underwent primary percutaneous coronary intervention.机器学习预测行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者无复流和住院死亡率。
BMC Med Inform Decis Mak. 2022 Apr 24;22(1):109. doi: 10.1186/s12911-022-01853-2.
10
Microvascular and Prognostic Effect in Lesions With Different Stent Expansion During Primary PCI for STEMI: Insights From Coronary Physiology and Intravascular Ultrasound.ST段抬高型心肌梗死直接经皮冠状动脉介入治疗中不同支架扩张病变的微血管及预后影响:来自冠状动脉生理学和血管内超声的见解
Front Cardiovasc Med. 2022 Mar 9;9:816387. doi: 10.3389/fcvm.2022.816387. eCollection 2022.